e-learning
resources
Berlin 2001
Monday 24.09.2001
Worldwide prevalence of asthma and atopy in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hospitalisation for acute asthma attack: audit for history of treatment and presence of infectious exacerbation
S. L. Silva, A. M. Teixeira, L. Pereira, C. Barreto, T. Bandeira, J. C. Trindade (Lisboa, Portugal)
Source:
Annual Congress 2001 - Worldwide prevalence of asthma and atopy in children
Session:
Worldwide prevalence of asthma and atopy in children
Session type:
Thematic Poster Session
Number:
1923
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. L. Silva, A. M. Teixeira, L. Pereira, C. Barreto, T. Bandeira, J. C. Trindade (Lisboa, Portugal). Hospitalisation for acute asthma attack: audit for history of treatment and presence of infectious exacerbation. Eur Respir J 2001; 16: Suppl. 31, 1923
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Under reporting acute exacerbation in patient with COPD: incidence and predictors?
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006
The management of NCFBE exacerbation
Source: School Course 2013 - Hot topics in the management of non-CF bronchiectasis
Year: 2013
Are we routinely using severity assessment in hospital admissions with acute severe asthma?
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008
Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 267s
Year: 2001
Effect of β
2
-agonists on severe asthma exacerbation and asthma-related hospitalization
Source: Eur Respir J 2007; 30: Suppl. 51, 352s
Year: 2007
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 928-933
Year: 2001
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Risk factors for hospitalization of an acute exacerbation of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Predictors of mortality in COPD during acute exacerbation
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
Influence of previous admissions on audit outcomes in patients admitted with acute exacerbation of COPD (AECOPD)
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Predictors of 90 day readmission in hospitalized patients for asthma exacerbation
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
High-risk patients following hospitalisation for an acute exacerbation of COPD
Source: Eur Respir J 2013; 42: 946-955
Year: 2013
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Rapid reduction in hospitalisations after an intervention to manage severe asthma
Source: Eur Respir J 2010; 35: 515-521
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept